Poland· PL-100477823
Emoxen
A naproxen and esomeprazole product containing naproxenum + esomeprazolum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Naproxen and esomeprazole is registered in 12 of 19 countries.
Countries holding a registration under ATC M01AE52 (naproxen and esomeprazole), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Naproxen and esomeprazole · ATC M01AE52
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naproxen and esomeprazole costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naproxen and esomeprazole · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.91
The record
At a glance
URPL (Poland)- Active substance
- Naproxenum + Esomeprazolum
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- M01AE52
- ATC class
- Naproxen and esomeprazole
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05397313000670
- gtin05397313000687
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for naproxen and esomeprazole.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naproxen and esomeprazole · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Naproxen and esomeprazole in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEMOXEN PLUSBausch Health Ireland Limited, Dublin
- United StatesNaproxen and esomeprazole magnesiumDr. Reddy's Laboratories Limited
- SwitzerlandNaproxen Esomeprazol Grünenthal 500 mg/20 mg, FilmtablettenGrünenthal Pharma AG
- IrelandNaproxen/Esomeprazole Abdi 500 mg/20 mg Modified Release TabletsAbdi Farma GmbH
- SpainEMOXEN 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFGBausch Health Ireland Limited
- CanadaMYLAN-NAPROXEN/ESOMEPRAZOLE MRMYLAN PHARMACEUTICALS ULC
- FinlandEmoxenduoBausch Health Ireland Limited
- NorwayVamtexarSandoz A/S
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Naproxen/Esomeprazol 1a Pharma, Naproxen/Esomeprazol Sandoz
- Belgium · Vimovo
- Bulgaria · Вимово
- Czechia · Emoxen Plus, Naproxen/Esomeprazole Abdi
- Germany · Naproxen/Esomeprazol Abdi, Vimovo
- Denmark · Emoxenduo
- Estonia · Esmapren, Naproxen/Esomeprazole Stada
- Spain · Emoxen, Naproxeno/Esomeprazol Cinfa
- Finland · Emoxenduo, Vamtexar
- United Kingdom (Northern Ireland) · Naproxen/Esomeprazole Msn Laboratories, Vimovo
- Croatia · Vamtexar, Xidofa
- Hungary · Apranax Plus
- Ireland · Naproxen / Esomeprazole Rowex, Naproxen/Esomeprazole Abdi
- Italy · Naprossene E Esomeprazolo Abdi, Vimovo
- Lithuania · Esmapren, Naproxen/Esomeprazole Stada
- Luxembourg · Vimovo
- Latvia · Esmapren, Naproxen/Esomeprazole Stada
- Netherlands · Vimovo
- Norway · Emoxenduo, Vamtexar
- Portugal · Naproxeno + Esomeprazol Sandoz, Vimovo
- Romania · Vimovo, Xidofa
- Sweden · Emoxenduo, Vimovo
- Slovenia · Combolly
- Slovakia · Emoxen Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2cc811e-e7ba-411b-8c1e-a94be2516130 GET /v1/drugs/c2cc811e-e7ba-411b-8c1e-a94be2516130?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o zmodyfikowanym uwalnianiu",
"source": "urpl",
"strength": "500 mg + 20 mg",
"packaging": "05397313000670 ¦ Rp ¦ 156525\n30 tabl.\n05397313000687 ¦ Rp ¦ 156526\n60 tabl.",
"substance": "Naproxenum 500 mg + Esomeprazolum 20 mg",
"common_name": "Naproxenum + Esomeprazolum",
"pl_product_id": "100477823",
"pozwolenie_nr": "28401",
"auth_procedure": "DCP",
"authorisation_validity": "2029-05-28"
}See everything about naproxen and esomeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.